Francisco Ruiz-Cabello

Citirano

	Sve	Od 2020.
Citati	13157	3432
H-indeks	66	33
i10-indeks	151	82

820

410

205

615

198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202534 62 90 50 90 94 150 159 130 154 241 273 288 324 372 314 365 306 418 370 292 374 378 452 619 507 384 520 537 549 681 559 801 646 676 685 61

Javni pristup

Prikaži sve

47 članaka

8 članaka

dostupno

nije dostupno

Na temelju uvjeta financiranja

Suautori

Ángel ConchaComplejo Hospitalario Universitario A Coruña, EspañaPotvrđena adresa e-pošte na sergas.es
Graham PawelecProfessor of Experimental ImmunologyPotvrđena adresa e-pošte na uni-tuebingen.de
Catia TraversariHead, Cell Therapy Production Unit _ IRCCS Carlo Besta Neurological InstitutePotvrđena adresa e-pošte na istituto-besta.it
Francisco X RealSenior Group Leader, CNIO, Madrid; Professor of Cell Biology, Universitat Pompeu Fabra, BarcelonaPotvrđena adresa e-pošte na cnio.es
Carlos CanoComputer Science and Artificial Intelligence, University of GranadaPotvrđena adresa e-pošte na decsai.ugr.es
Francisco F NogalesProfessor Emeritus of Pathology. University of Granada Med. School, SpainPotvrđena adresa e-pošte na ugr.es
Enrique Fernández MondejarHospital Virgen de las Nieves, Universidad de GranadaPotvrđena adresa e-pošte na juntadeandalucia.es
JOSE GUTIERREZ-FERNANDEZ (http...Full Professor of Microbiology / Microbiologist. Granada University "Hospital Virgen de las Nieves"Potvrđena adresa e-pošte na ugr.es
MANUEL ELKIN PATARROYO MURIL...Fundación Instituto de Inmunología de Colombia (FIDIC)Potvrđena adresa e-pošte na fidic.org.co
Stephen WardProfessor of Pharmacology, University of BathPotvrđena adresa e-pošte na bath.ac.uk
Miguel Ángel Rodríguez ValverdeUniversidad de GranadaPotvrđena adresa e-pošte na ugr.es
Miguel Angel Cabrerizo VilchezProfesor de FísicaPotvrđena adresa e-pošte na ugr.es
Cristóbal Romero (ORCID: 0000-0003...Full Professor in University of Cordoba and member of KDIS Research GroupPotvrđena adresa e-pošte na uco.es
Halim KusumaatmajaJason Reese Chair, University of EdinburghPotvrđena adresa e-pošte na ed.ac.uk
J. Miguel Angel Garcia-MartinezProfesor de Psicología Social, Universidad de GranadaPotvrđena adresa e-pošte na ugr.es
Ignacio Benites MorenoProfessor, Universidade Federal do Rio Grande do Sul - CECLIMAR/UFRGSPotvrđena adresa e-pošte na ufrgs.br
David E LevyProfessor of Pathology and Microbiology, NYU School of MedicinePotvrđena adresa e-pošte na nyulangone.org

Prati

Francisco Ruiz-Cabello

Universidad de Granada, Departamento de Bioquímica y Biología Molecular III/Inmunología

Potvrđena adresa e-pošte na ugr.es

Immunology Oncology Tumor Immunology


Naslov Poredaj po navodima Poredaj po godini Poredaj po naslovu	Citirano Citirano	Godina
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours F Garrido, F Ruiz-Cabello, T Cabrera, JJ Perez-Villar, M López-Botet, ... Immunology today 18 (2), 89-95, 1997	1049	1997
Natural history of HLA expression during tumour development F Garrido, T Cabrera, A Concha, S Glew, F Ruiz-Cabello, PL Stern Immunology today 14 (10), 491-499, 1993	609	1993
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles MI Lucena, M Molokhia, Y Shen, TJ Urban, GP Aithal, RJ Andrade, ... Gastroenterology 141 (1), 338-347, 2011	524	2011
The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape I Algarra, A García-Lora, T Cabrera, F Ruiz-Cabello, F Garrido Cancer Immunology, Immunotherapy 53, 904-910, 2004	399	2004
Rexpression of HLA class I antigens and restoration of antigen‐specific CTL response in melanoma cells following 5‐aza‐2′‐deoxycytidine treatment A Serrano, S Tanzarella, I Lionello, R Mendez, C Traversari, ... International journal of cancer 94 (2), 243-251, 2001	300	2001
Analysis of HLA-E expression in human tumors R Marín, F Ruiz-Cabello, S Pedrinaci, R Méndez, P Jiménez, ... Immunogenetics 54, 767-775, 2003	235	2003
Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: β₂‐microglobulin inactivation in MSI‐positive tumors and LMP7/TAP2 … CM Cabrera, P Jimenez, T Cabrera, C Esparza, F Ruiz‐Cabello, ... Tissue antigens 61 (3), 211-219, 2003	209	2003
Immune escape of cancer cells with beta2‐microglobulin loss over the course of metastatic melanoma AB Del Campo, JA Kyte, J Carretero, S Zinchencko, R Méndez, ... International journal of cancer 134 (1), 102-113, 2014	195	2014
Mutations of the β₂‐microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides R Benitez, D Godelaine, MA Lopez‐Nevot, F Brasseur, P Jimenez, ... Tissue antigens 52 (6), 520-529, 1998	189	1998
HLA class I antigens in human tumors F Garrido, T Cabrera, MA Lopez-Nevot, F Ruiz-Cabello Advances in cancer research 67, 155-195, 1995	178	1995
MHC class I antigens and immune surveillance in transformed cells N Aptsiauri, T Cabrera, A Garcia‐Lora, MA Lopez‐Nevot, F Ruiz‐Cabello, ... International review of cytology 256, 139-189, 2007	177	2007
Role of altered expression of HLA class I molecules in cancer progression N Aptsiauri, T Cabrera, R Mendez, A Garcia-Lor, F Ruiz-Cabello, ... Immune-Mediated Diseases: From Theory to Therapy, 123-131, 2007	177	2007
Rejection versus escape: the tumor MHC dilemma F Garrido, F Ruiz-Cabello, N Aptsiauri Cancer immunology, immunotherapy 66, 259-271, 2017	175	2017
Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy R Carretero, JM Romero, F Ruiz-Cabello, I Maleno, F Rodriguez, ... Immunogenetics 60, 439-447, 2008	172	2008
Coordinated downregulation of the antigen presentation machinery and HLA class I/β2‐microglobulin complex is responsible for HLA‐ABC loss in bladder cancer JM Romero, P Jiménez, T Cabrera, JM Cózar, S Pedrinaci, M Tallada, ... International journal of cancer 113 (4), 605-610, 2005	170	2005
Multiple mechanisms underlie HLA dysregulation in cervical cancer CS Brady, JS Bartholomew, DJ Burt, MF Duggan‐Keen, S Glenville, ... Tissue antigens 55 (5), 401-411, 2000	165	2000
HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas MA Lopez-Nevot, F Esteban, A Ferron, J Gutierrez, MR Oliva, C Romero, ... British journal of cancer 59 (2), 221-226, 1989	162	1989
Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes M Bernal, F Ruiz-Cabello, A Concha, A Paschen, F Garrido Cancer immunology, immunotherapy 61, 1359-1371, 2012	158	2012
Analysis of HLA expression in human tumor tissues T Cabrera, M López-Nevot, J Gaforio, F Ruiz-Cabello, F Garrido Cancer Immunology, Immunotherapy 52, 1-9, 2003	158	2003
Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors P Jiménez, J Cantón, A Collado, T Cabrera, A Serrano, LM Real, A García, ... International journal of cancer 83 (1), 91-97, 1999	155	1999

Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.

Članci 1–20

Godišnji broj citata

Dvostruki navodi

Spojeni navodi

Dodavanje suautoraSuautori

Prati

Citirano

Suautori